Epitomee Medical Ltd (EPIT) — Cash Flow-to-Debt Ratio
Epitomee Medical Ltd (EPIT) has a Cash Flow-to-Debt Ratio of -2.02x as of June 2025, meaning its operating cash flow of ILA-12.78 Million could theoretically repay -2% of its total liabilities (ILA6.32 Million) in one year. See Epitomee Medical Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Epitomee Medical Ltd Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Epitomee Medical Ltd across 6 annual periods. Also explore Epitomee Medical Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Epitomee Medical Ltd (2019–2024)
Year-by-year debt coverage analysis for Epitomee Medical Ltd. For market capitalisation and broader financial context, see Epitomee Medical Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.32x | ILA-8.29 Million | ILA6.26 Million | ▲ +8.6% |
| 2023 | -1.45x | ILA-7.92 Million | ILA5.46 Million | ▼ -142.4% |
| 2022 | -0.60x | ILA-9.42 Million | ILA15.76 Million | ▼ -32.1% |
| 2021 | -0.45x | ILA-5.76 Million | ILA12.73 Million | ▼ -216.3% |
| 2020 | 0.39x | ILA6.75 Million | ILA17.34 Million | ▲ +111.1% |
| 2019 | -3.51x | ILA-2.79 Million | ILA794.00K | — |